Covid-19 Vaccine mixing of covishield and covaxin more safe and effective against coronavirus says ICMR study

Covid-19 Vaccine: Combination of Covishield, Covaxin more effective against corona, important disclosure in ICMR study

The ICMR study has revealed that mixing Covaccine and Covishield gives better results.

Covid-19 Vaccine India: Vaccination against corona virus is going on in the country. In such a situation, now an important study has come out. The ICMR study has revealed that mixing Covaccine and Covishield gives better results. It has been told in the study that the combination of both of them is not only safe, but it also provides better immunogenicity. Along with this, the side effects also remain the same as taking both the vaccines.

98 people were involved in this study of ICMR. Of these, 18 people from Uttar Pradesh inadvertently took the first dose of Covishield and the second dose of Covaccine.

A different dose was taken unknowingly in Uttar Pradesh

The vaccination campaign against COVID-19 in India started with two vaccines. These included the adenovirus vector platform-based vaccine CovaShield and the inactivated whole virion BBV152-Covaccine. In these, it was decided to give both doses of the same vaccine. However, in Siddharthnagar, Uttar Pradesh, 18 people were unknowingly given the first dose of Covishield and the second dose of Covaccine. At that time, the fourth month of the ongoing vaccination program was going on across the country. And this incident caused concern among the people. This also increased the hesitation among people about the vaccine. Now a study has been done about it.

Apart from 18 people who took different vaccine doses, 40 such people were included in this study who had taken both doses of Covishield. And 40 people were taken to take both doses of the vaccine. The study was done between May and June 2021.

Covid-19: 39,070 new cases of corona in the country, 491 deaths

The study said that in this the safety and immunity of 18 people were compared to those who took both doses of Covishield and Covaccine. The side effects were found to be less or similar, indicating safety. Also, they found greater immunogenicity against alpha, beta and delt variants. Apart from this, both the IgG antibody and the neutralizing antibody response of people were higher than those taking the same vaccine.

Get Business News ,, latest India News ,, and other breaking news on share market, investment scheme and much more on Business Khabar. Like us on Facebook, Follow us on Twitter for latest financial news and share market updates.

.

realistic reality mobile new
Default image
Business Khabar
We aim to constantly bring to you all the latest and most updated industry news across all major categories. With a wide variety of topics and categories under our umbrella, we bring to you the latest news and activities in the top sought areas of public interest.
Articles: 5415